Rituximab in the treatment of acute cellular rejection of renal allograft with CD20-positive clusters in the infiltrate

Clinical and Experimental Nephrology

Volumn 15, Issue 2, 2011, Pages 308-311

  Vega, Jorge ^a,b   Goecke, Helmuth ^a,b   Carrasco, Alejandra ^b   Escobar, Carlos ^b   Escobar, Max ^b   Espinosa, Roberto ^b   Méndez, Gonzalo ^c   De Los Ángeles Rodríguez, María ^b  

^a UNIVERSIDAD DE VALPARAÍSO   (Chile)

^b HOSPITAL NAVAL ALMIRANTE NEF   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Acute rejection; B lymphocytes; Kidney transplantation; Mycophenolate; Prognosis; Rituximab; Treatment

Indexed keywords

AZATHIOPRINE; CD20 ANTIBODY; CYCLOSPORIN; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; TACROLIMUS; VALGANCICLOVIR;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; ENDARTERITIS; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LEUKOCYTOCLASTIC VASCULITIS; LYMPHOCYTIC INFILTRATION; NEPHRONOPHTHISIS; POSTOPERATIVE CARE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; B-LYMPHOCYTES; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; T-LYMPHOCYTES;

EID: 79959270943     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0387-8     Document Type: Article

References (14)

1. Celik A, Saglam F, Cavdar C, Sifil A, Atila K, Sarioglu S, et al. Successful therapy with rituximab of refractory acute humoral renal transplant rejection: a case report. Transplant Proc. 2008; 40:302-4.
2. Ibernón M, Gil-Vernet S, Carrera M, Serón D, Moreso F, Bestard O, et al. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplant Proc. 2005;37:3743-5.
3. Moscoso-Solorzano GT, Baltar JM, Seco M, López-Larrea C, Mastroianni-Kirsztajn G, Ortega F. Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report. Transplant Proc. 2007; 39:3460-2.
4. Steinmetz OM, Lange-Hüsken F, Turner JE, Vernauer A, Helmchen U, Stahl RA, et al. Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection. Transplantation. 2007;84:842-50. (Pubitemid 351338944)
5. Faguer S, Kamar N, Guilbeaud-Frugier C, Fort M, Modesto A, Mari A, et al. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation. 2007;83:1277-80. (Pubitemid 46743692)
6. Alausa M, Almagro U, Siddiqi N, Zuiderweg R, Medipalli R, Hariharan S. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab. Clin Transplant. 2005;19:137-40. (Pubitemid 40227865)
7. Becker YT, Becker BN, Pirsch JD, Sollinger HW. Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant. 2004;4:996-1001. (Pubitemid 38745599)
8. Lehnhardt A, Mengel M, Pape L, Ehrich JH, Offner G, Strehlau J. Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by Rutuximab. Am J Transplant. 2006;6:847-51. (Pubitemid 43345024)
9. Pescovitz MD. Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant. 2006; 6:859-66. (Pubitemid 44356635)
10. Genberg H, Hansson A, Wernerson A, Wennberg L, Tydén G. Pharmacodynamics of rituximab in kidney allotransplantation. Am J Transplant. 2006;6:2418-28. (Pubitemid 44359429)
11. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8:753-60. (Pubitemid 351347767)
12. Montgomery RA, Hardy MA, Jordan SC, Racusen LC, Ratner LE, Tyan DB, et al. Consensus opinion from the Antibody Working Group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols. Transplantation. 2004;78:181-5.
13. Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med. 2003;349:125-38. (Pubitemid 36818782)
14. Hippen B, DeMattos A, Cook W, Kew CE 2nd, Gaston RS. Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant. 2005;5:2248-52. (Pubitemid 41648473)